Laboratory diagnosis of visceral leishmaniasis

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 5, 2002, Pages 951-958

  Sundar, Shyam ^a   Rai, M ^a  

^a NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA DONOVANI; MIXED INFECTION; PARASITE ISOLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; SKIN TEST; VISCERAL LEISHMANIASIS;

ANIMALS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL;

EID: 0036733664     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.5.951-958.2002     Document Type: Article

References (86)

1. Detection of leishmania in blood of early kala-azar patients with the aid of polymerase chain reaction
2. The role of counter immunoelectrophoresis as a diagnostic tool for kala-azar
3. Leishmaniasis: New perspectives on an underappreciated opportunistic infection
4. Leishmania and human immunodeficiency virus coinfection: The first 10 years
5. Diagnosis of visceral leishmaniasis by polymerase chain reaction using blood, bone marrow and lymphnode samples from patients from the Sudan
6. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis
7. rK39: A cloned antigen for Leishmania chagasi that predicts active visceral leishmaniasis
8. Ethiopian visceral leishmaniasis patients co-infection with human immunodeficiency virus
9. Use of the recombinant k39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal
10. Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis
11. Multicenter evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis
12. Epidemiology of visceral leishmaniasis in India
13. Immunodiagnosis of leishmaniasis
14. Immunodiagnosis of leishmaniasis
15. Experimental leishmaniasis of mammals
16. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in both African and American visceral leishmaniasis
17. Detection of leishmania in immunocompromised patients using peripheral blood spot on filter paper and the polymerase chain reaction
18. Enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Bhadohi (Varanasi)
19. Quantitation of amastigotes of Leishmania donovani in smears of spleenic aspirates from patients with visceral leishmaniasis
20. Detection of 72-75 kD and 123 kD fractions of leishmania antigen in urine of patients with visceral leishmaniasis
21. Global control and Leishmania HIV co-infection
22. The increase in risk factors for leishmaniasis worldwide
23. Polyclonal B-cell activation, circulating immune complexes and autoimmunity in human visceral leishmaniasis
24. Survivability and infectivity of viscerotropic Leishmania tropica from operation desert storm participants in human blood product maintained under blood bank conditions
25. Serologic profiles in Indian post kala-azar dermal leishmaniasis
26. Cell-mediated immune response in Indian kala-azar and post kala-azar dermal leishmaniasis
27. Improvement of a direct agglutination test for field studies of visceral leishmaniasis
28. Leishmaniasis
29. The culture of Leishmania donovani in Schneider's insect medium: Its value in the diagnosis and management of patients with visceral leishmaniasis
30. A complement fixation test for visceral leishmaniasis using homologous parasite antigen 1
31. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy
32. Characterization of phosphoglycan containing secretory products of leishmania
33. Species-specific antibodies to Leishmania tropica (minor) recognize somatic antigens and exometabolites
34. Sensitivity and specificity of a rapid immunochromatographic test for diagnosis of visceral leishmaniasis
35. Identification and genetic comparison of leishmanial parasites causing viscerotropic and cutaneous disease in soldiers returning from Operation Desert Storm
36. Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis
37. Comparison of various sample preparation methods of PCR diagnosis of visceral leishmaniasis using peripheral blood
38. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France
39. On the possibility of occurrence of trypanosomiasis in India
40. The use of non-radioactive DNA probes for the characterization of leishmania isolates from Peru
41. Viscerotropic leishmaniasis caused by Leishmania tropica in soldiers returning from Operation Desert Storm
42. Mucosal leishmaniasis (espundia Escomel 1911)
43. Clinical manifestations, diagnosis and treatment of leishmaniasis
44. Diagnosis of infection with Leishmania infantum using PCR-ELISA
45. The value of a direct agglutination test in the diagnosis of cutaneous and visceral leishmaniasis in Ethiopia
46. Rapid identification of causative species in patients with Old World leishmaniasis
47. Molecular tracking of infections by Leishmania infantum
48. Pleural and peritoneal leishmaniasis in an AIDS patient
49. Evaluation of the direct agglutination test (DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in stored sera from various patient groups in Ethiopia
50. Use of polymerase chain reaction to assess the success of visceral leishmaniasis treatment
51. Evaluation of PCR for diagnosis of visceral leishmaniasis
52. Use of PCR on lymph node samples as test of cure of visceral leishmaniasis
53. Leishmania donovani: Titration of the antibodies to the fucose mannose ligand as an aid in the diagnosis and prognosis of visceral leishmaniasis
54. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients
55. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of Leishmania kinesin
56. Optimisation of an ELISA for the serodiagnosis of visceral leishmaniasis using in vitro derived promastigote antigens
57. Post kala-azar dermal leishmaniasis
58. HIV and leishmania coinfection: A review of 91 cases with focus on atypical locations of leishmania
59. Visceral leishmaniasis and HIV co-infection in Southern France
60. Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis
61. Indian kala-azar caused by Leishmania tropica
62. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis
63. A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis
64. Parasitological techniques
65. Epidemic visceral leishmaniasis in Southern Sudan: Treatment of severely debilitated patients under wartime conditions with limited resources
66. Visceral leishmaniasis in Somalia, prevalence of leishmanin positive and seropositive inhabitants in an endemic area
67. Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis
68. Recent advances in the laboratory diagnosis of leishmaniasis
69. Comparative evaluation of serological tests in Indian kala-azar
70. Antigenic cross reactivity between Mycobacterium bovis (BCG) and Leishmania donovani
71. Rapid and sensitive detection of leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients
72. Comparative evaluation of DAT, IFAT and micro-ELISA in the serodiagnosis of Indian kala-azar
73. Immunochromatogaphic strip test detection of anti k39 antibody in Indian visceral leishmaniasis
74. Resistance to treatment in kala-azar: Speciation of isolates from Northeast India
75. Rapid accurate field diagnosis of visceral leishmaniasis
76. Socioeconomics of visceral leishmaniasis in Bihar (India)
77. Post kala-azar dermal leishmaniasis: A neglected aspect of kala-azar control programmes
78. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar
79. Anti-66 kDa anti-leishmanial antibodies as specific immunodiagnostic probe for visceral leishmaniasis
80. Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction
81. Endemic kala-azar in eastern Sudan: Post kala-azar dermal leishmaniasis
82. Direct agglutination test for diagnosis and seroepidemiological survey of kala-azar in the Sudan
83. Kala-azar: A comparative study of parasitological methods and the direct agglutination test in diagnosis
84. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: Experience from the Sudan